4Jung YK, Yeon JE, Choi JH, et al. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient[J]. Gut Liver, 2010, 3: 389-393.
5Hamnvik OP, Becker CB, Levy BD, et al. Clinical problem-solving. Wasting away[J]. N Engl J Meal, 2014, 370: 959-966.
2Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial [ J ]. JAMA, 1999, 282 (24) : 2305 -2312.
3Fisher E J, Chaloner K, Cohn DL, et al. The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial[J]. AIDS, 2001,15(13) : 1695-700.
4Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B [J]. Hepatology, 2009, 49 ( Suppl 5 ) : S185 -195.
5Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B : two double-blind, randomized, placebo-controlled studies[J]. Kidney Int, 2004, 66(3) : I153-I158.
6卢义侠.肾小管疾病的临床症状及诊治.中国综合临床,1987,3(5):271-273.
7Tamori A, Enomoto M, Kobayashi S, et al. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus. J Viral Hepat, 2010, 17 : 123-129.
8Wong T, Girgis CM, Ngu MC, et al. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab,2010, 95:479-480.
9Girgis CM, Wong T, Ngu MC, et al. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol,2011,45 :468-473.
10Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA, 1999, 282:2305-2312.
4Jung YK, Yeon JE, Choi JH, et al. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient[J]. Gut and Liver,2010,4:389-393.
5Hamnvik OP, Becker CB, Levy BD, et al. Clinical problem-solving. Wasting away[J]. N Engl J Med,2014,370:959-966.
6Hannon H, Bagnis CI, Benhamou Y, et al. The renal tolerance of lowdose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV[J]. Nephrol Dial Transplant,2004,19:386-390.
7Izzedine H, Hulot JS, Launay- Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies[J]. Kidney Int,2004,66:1153- 1158.
8Jeong HJ, Lee JM, Lee TH, et al. Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review[J]. J Bone Metab,2014,21:76-83.
9EGUCHI H, TSURUTA M, TANI J, et al. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B [ J ]. Intern Med, 2014, 53(3): 233-237.
10SHIMOHATA H, SAKAIS, OGAWA Y, et al. Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil [ J ]. Clin Exp Nephrol, 2013, 17 (1): 147-148.
